Indinavir analogues with blocked metabolism sites as HIV protease inhibitors with improved pharmacological profiles and high potency against PI-resistant viral strains
被引:24
作者:
Cheng, Y
论文数: 0引用数: 0
h-index: 0
机构:
Merck Res Labs, Dept Med Chem, Rahway, NJ 07065 USAMerck Res Labs, Dept Med Chem, Rahway, NJ 07065 USA
Cheng, Y
[1
]
Zhang, FQ
论文数: 0引用数: 0
h-index: 0
机构:Merck Res Labs, Dept Med Chem, Rahway, NJ 07065 USA
Zhang, FQ
Rano, TA
论文数: 0引用数: 0
h-index: 0
机构:Merck Res Labs, Dept Med Chem, Rahway, NJ 07065 USA
Rano, TA
Lu, ZJ
论文数: 0引用数: 0
h-index: 0
机构:Merck Res Labs, Dept Med Chem, Rahway, NJ 07065 USA
Lu, ZJ
Schleif, WA
论文数: 0引用数: 0
h-index: 0
机构:Merck Res Labs, Dept Med Chem, Rahway, NJ 07065 USA
Schleif, WA
Gabryelski, L
论文数: 0引用数: 0
h-index: 0
机构:Merck Res Labs, Dept Med Chem, Rahway, NJ 07065 USA
Gabryelski, L
Olsen, DB
论文数: 0引用数: 0
h-index: 0
机构:Merck Res Labs, Dept Med Chem, Rahway, NJ 07065 USA
Olsen, DB
Stahlhut, M
论文数: 0引用数: 0
h-index: 0
机构:Merck Res Labs, Dept Med Chem, Rahway, NJ 07065 USA
Stahlhut, M
Rutkowski, CA
论文数: 0引用数: 0
h-index: 0
机构:Merck Res Labs, Dept Med Chem, Rahway, NJ 07065 USA
Rutkowski, CA
Lin, JH
论文数: 0引用数: 0
h-index: 0
机构:Merck Res Labs, Dept Med Chem, Rahway, NJ 07065 USA
Lin, JH
Jin, LX
论文数: 0引用数: 0
h-index: 0
机构:Merck Res Labs, Dept Med Chem, Rahway, NJ 07065 USA
Jin, LX
Emini, EA
论文数: 0引用数: 0
h-index: 0
机构:Merck Res Labs, Dept Med Chem, Rahway, NJ 07065 USA
Emini, EA
Chapman, KT
论文数: 0引用数: 0
h-index: 0
机构:Merck Res Labs, Dept Med Chem, Rahway, NJ 07065 USA
Chapman, KT
Tata, JR
论文数: 0引用数: 0
h-index: 0
机构:Merck Res Labs, Dept Med Chem, Rahway, NJ 07065 USA
Tata, JR
机构:
[1] Merck Res Labs, Dept Med Chem, Rahway, NJ 07065 USA
[2] Merck Res Labs, Dept Viral Vaccine Res, West Point, PA 19486 USA
[3] Merck Res Labs, Dept Biol Chem, West Point, PA 19486 USA
[4] Merck Res Labs, Dept Drug Metab, West Point, PA 19486 USA
Indinavir analogues with blocked metabolism sites show highly improved pharmacokinetic profiles in animals. The cis aminochromanol substituted analogues exhibited excellent potency against both the wild-type (NL4-3) virus and protease inhibitor-resistant HIV strains. (C) 2002 Elsevier Science Ltd. All rights reserved.